Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Robinson

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Translational Medicine|March 10, 2012
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancerXiwei Wu, George Somlo, Yang Yu, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cell|September 24, 2016
Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome ActivationFranklin L Zhong, Ons Mamaï, Lorenzo Sborgi, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Translational Medicine|March 10, 2012
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancerXiwei Wu, George Somlo, Yang Yu, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cell|September 24, 2016
Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome ActivationFranklin L Zhong, Ons Mamaï, Lorenzo Sborgi, et al.
Pageof 4